Literature DB >> 24240195

Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.

Ke Zhang1, Karl-Josef Langen, Irene Neuner, Gabriele Stoffels, Christian Filss, Norbert Galldiks, Lutz Tellmann, Elena Rota Kops, Heinz H Coenen, Hans Herzog, Nadim J Shah.   

Abstract

OBJECTIVES: O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) is an established tracer for brain tumour imaging. (18)F-FET kinetics in gliomas appear to have potential for tumour grading, but the mechanisms remain unclear. The aim of this study was to explore the relationship between regional cerebral blood flow (rCBF) as measured by arterial spin labelling MRI and the kinetic behaviour of (18)F-FET PET in cerebral gliomas.
MATERIALS AND METHODS: Twenty patients with cerebral gliomas were investigated using arterial spin labelling MRI and dynamic (18)F-FET PET. Time-activity curves (TACs) of (18)F-FET uptake were analysed in 33 different tumour regions. The slopes of TAC during the early (0-5 min; slopeup) and late phases of tracer uptake (17-50 min; slopedown) were fitted using linear regression lines. In addition, TACs of each lesion were assigned to different curve patterns. Furthermore, we calculated tumour-to-brain ratios of (18)F-FET uptake. The relationship between (18)F-FET parameters and rCBF was determined.
RESULTS: (18)F-FET uptake in the early phase (slopeup) showed a significant correlation with rCBF (r=0.4; P=0.02). In contrast, both slopedown and TAC patterns showed no significant correlation with rCBF. Furthermore, a significant correlation was found between rCBF and tumour-to-brain ratio (r=0.53; P=0.002).
CONCLUSION: There is a relationship between rCBF and (18)F-FET uptake in cerebral gliomas in the initial uptake phase, but the kinetic behaviour of (18)F-FET uptake in the late phase is not significantly influenced by rCBF. Thus, the differential kinetic pattern of (18)F-FET uptake in high-grade and low-grade gliomas appears to be determined by factors other than rCBF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24240195     DOI: 10.1097/MNM.0000000000000036

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysis.

Authors:  Alberto Falk Delgado; Francesca De Luca; Danielle van Westen; Anna Falk Delgado
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

Review 2.  Positron emission tomography of high-grade gliomas.

Authors:  Guido Frosina
Journal:  J Neurooncol       Date:  2016-02-20       Impact factor: 4.130

Review 3.  6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.

Authors:  M Pretze; C Wängler; B Wängler
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

4.  Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.

Authors:  Paul Blanc-Durand; Axel Van Der Gucht; Antoine Verger; Karl-Josef Langen; Vincent Dunet; Jocelyne Bloch; Jean-Philippe Brouland; Marie Nicod-Lalonde; Niklaus Schaefer; John O Prior
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

5.  Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation.

Authors:  Lena Vomacka; Marcus Unterrainer; Adrien Holzgreve; Erik Mille; Astrid Gosewisch; Julia Brosch; Sibylle Ziegler; Bogdana Suchorska; Friedrich-Wilhelm Kreth; Jörg-Christian Tonn; Peter Bartenstein; Nathalie Lisa Albert; Guido Böning
Journal:  EJNMMI Res       Date:  2018-09-10       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.